Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Taiwan · Delayed Price · Currency is TWD

31.80

-0.05 (-0.16%)

At close: Jul 9, 2026

-9.40% (1Y)

Market Cap	3.21B -13.2%
Revenue (ttm)	2.11B -6.2%
Net Income	204.95M -21.4%
EPS	2.02 -21.4%
Shares Out	100.99M
PE Ratio	15.74
Forward PE	n/a
Dividend	1.60 (5.02%)
Ex-Dividend Date	Jul 2, 2026

Volume	45,176
Open	32.45
Previous Close	31.85
Day's Range	31.70 - 32.45
52-Week Range	31.55 - 40.70
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1963

Employees 552

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 1752

Full Company Profile

Financial Performance

In 2025, Nang Kuang Pharmaceutical's revenue was 2.16 billion, a decrease of -1.71% compared to the previous year's 2.20 billion. Earnings were 244.41 million, an increase of 0.41%.

Financial Statements